Skip to main content
. 2021 Jan 15;48(8):2566–2572. doi: 10.1007/s00259-020-05177-z

Table 2.

[177Lu]Lu-DOTA-EB-TATE to [177Lu]Lu-DOTA-TOC absorbed dose ratios

Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Mean Median p
Whole body 7.2 4.9 14.8 8.1 3.0 7.6 7.2 0.03
Kidneys 3.2 2.7 9.8 5.1 1.6 4.5 3.2 0.07
Tumours 1.7 3.9 1.7 0.9 1.6 2.0 1.7 0.13
Spleen 4.7 1.2 5.2 6.2 2.8 4.0 4.7 0.03
Liver 3.3 0.7 4.7 4.9 3.4 4.0 0.09

The liver of Patient 5 was not evaluable due to hepatic metastasis